Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-09-28

FDA Approved: MICAFUNGIN — Original Application (Meitheal Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved Meitheal Pharmaceuticals' original application for micafungin sodium (micafungin) injection, a generic antifungal, for treating candidemia/inva…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Micafungin sodium (Micafungin)

Snippet

ORIG AP for MICAFUNGIN (MICAFUNGIN SODIUM)